# Study of TAK-672 in Participants With Acquired Hemophilia A

> **NCT04580407** · PHASE2,PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 5 (actual)

## Conditions studied

- Acquired Hemophilia A

## Interventions

- **BIOLOGICAL:** TAK-672

## Key facts

- **NCT ID:** NCT04580407
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-09
- **Primary completion:** 2022-11-29
- **Final completion:** 2022-11-29
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2024-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04580407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04580407, "Study of TAK-672 in Participants With Acquired Hemophilia A". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04580407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*